SEMA6C and exocrine pancreatic carcinoma: Intriguingly, Sema6C-binding antibodies have been recently shown to stimulate pancreatic carcinoma cell proliferation, possibly neutralizing a suppressor activity [10]; however the implicated mechanisms and relevance in cancer remain unclear.